Botulinum toxin-like polypeptide nano-micelles and preparation method and application thereof
By designing and preparing botulinum polypeptide-like nanomicrobials, the problems of peptide penetration of skin barriers and allergies in nano-gold carriers are solved, efficient anti-wrinkle and firming effects are achieved, and the product biocompatibility and safety is improved.
Patent Information
- Application Number
- CN202211447850.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-11-18
- Publication Date
- 2024-11-19
- Estimated Expiration
- 2042-11-18
AI Technical Summary
Existing peptide products have difficulties in penetrating the skin barrier, resulting in low bioavailability, and the use of nano-gold carriers may cause allergic reactions and inflammation problems.
Design a botox-like polypeptide nanomilk, simulate the peptide sequence through Discovery studio software, perform hydrophobic group modification, and prepare nanomilk through solid-phase organic synthesis technology to form supramolecular nanoparticles with ester-philic core and hydrophilic shell , avoid exogenous substances, improve transdermality and safety.
The rapid penetration of the skin barrier of the peptide is achieved, which significantly improves the anti-wrinkle effect, avoids the allergic hazards of nano-gold, enhances biocompatibility and safety, and can load other hydrophilic peptides to exert tightening and anti-inflammatory effects.
Smart Images

Figure CN116327610B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of cosmetics, and in particular relates to a botulinum toxin-like polypeptide nano-micelle and a preparation method and application thereof. Background Art
[0002] Wrinkles are the first sign of skin aging. As we age, the contraction strength of facial muscles decreases, skin tension also decreases, and wrinkles begin to appear on elastic skin. There are many internal and external factors for this phenomenon. The internal factors are mainly due to the gradual weakening of the body's own regeneration ability with age; the external factors include ultraviolet and electromagnetic radiation, long-term staying up late, etc. The combined effect of these internal and external factors will cause facial skin to show characteristics such as deeper and more wrinkles, sagging skin, and a large loss of collagen.
[0003] Due to natural aging and other reasons, the formation of wrinkles is unavoidable, but it can be delayed through anti-wrinkle methods. The existing technology uses the method of injecting botulinum toxin type A to remove wrinkles. Botulinum toxin type A is a neurotoxin protein produced by Clostridium botulinum during the reproduction process. It is 150kD in size and acts by inhibiting the release of acetylcholine from the presynaptic membrane of peripheral motor nerve endings, thereby causing muscle relaxation paralysis and inhibiting muscle contraction. However, botulinum toxin also faces many problems when used as a wrinkle removal product. First, botulinum toxin needs to be injected to work and the effect is limited in time after one injection; secondly, botulinum toxin is expensive and has a relatively small audience; most importantly, improper operation and use can cause users to have sequelae such as facial stiffness and facial paralysis.
[0004] With the progress of research, the emergence of hexapeptide has greatly improved the safety of anti-wrinkle. Compared with botulinum toxin, hexapeptide is non-irritating, safe, has no surgical risk, no age skin quality requirements, and does not require injection. It is not easy to leave sequelae such as facial stiffness and facial paralysis. Hexapeptide is one of the most classic peptides against expression lines. It competes with SNAP-25 to interfere with the formation of the SNARE protein ternary complex, inhibits the excessive release of neurotransmitters, and exerts anti-wrinkle effects. Applying 10% lotion to the corners of the eyes for 30 days can reduce the depth of crow's feet at the corners of the eyes by 30%, which is a very effective anti-wrinkle active substance. There are also some other anti-wrinkle peptides on the market, such as velos peptide, which can reduce eye wrinkles by 49% and skin roughness by 47% within 28 days; snake venom peptide, a small molecule active peptide that simulates snake venom toxin, can effectively reduce the formation of wrinkles. And it will not affect facial expressions. Through efficacy verification experiments, when 25ppm of snake venom peptide solution was used on cultured cells, the muscle contraction rate was reduced to 36% after one minute and to 82% after 2 hours, which can achieve an instant wrinkle removal effect.
[0005] Whether it is the above-mentioned hexapeptide or products such as velos peptide, most of them are short peptides. For peptide products, the longer the peptide chain, the more difficult it is to penetrate the skin barrier. For example, CN113402586A discloses a polypeptide and its use as a muscle paralysis relaxant or skin anti-wrinkle agent, and its polypeptide sequence is: R-Glu-Glu-Met-Gln-Arg-Arg-Ala, wherein R is selected from at least one of Ser, Glu, Phe, Met, Arg, Asn, Glu and Leu. From the perspective of polypeptide structure, the shortest is an octapeptide and the longest is a 15-peptide. When the amino acid sequence exceeds 10, its skin permeability will inevitably be affected, and when it is 15 peptides, the permeability will be further weakened; therefore, although the 15-peptide imitating type A botulinum toxin prepared in this patent has good stability, permeability and affinity, and exhibits good biocompatibility, and is used for relaxation of facial expression muscle paralysis, it has achieved the effect of improving facial contours and eliminating or reducing wrinkles, but its skin permeability is reduced, most of it stays in the stratum corneum, and only a very small part penetrates the skin into the epidermis and dermis. Therefore, its bioavailability is greatly reduced, the efficacy is limited, and it does not actually solve the permeability problem when the peptide chain is extended. Therefore, the existing peptide products on the market will increase their permeability by reducing the length of the peptide chain, which will also abandon many parts of the peptide chain that play a role, resulting in reduced efficacy of the peptide.
[0006] In order to improve the permeability of polypeptides, CN113512092A discloses a polypeptide nanohybrid with good effect of eliminating or reducing wrinkles. The structure of the polypeptide nanohybrid is [Au-SS-pentadecapeptide]n, and the amino acid sequence of the pentadecapeptide is SEFMRNELEEMQRRA. After being modified by Cys, it is prepared into a hybrid with nanogold, and the pentadecapeptide is delivered transdermally with the help of a nanogold carrier. According to its technical solution: the final form of the nanohybrid is an acidic solution, containing hydroxyethylpiperazineethylsulfonic acid and chloroauric acid, with a relatively low pH. Nanogold itself is an exogenous substance. When used in injectable preparations, it is easy to cause the polypeptide and gold to dissociate. The gold ions lack the ability to pass through the skin barrier, and there are certain allergic risks. These allergic risks can cause skin breakage, micro-injury, induce phagocytosis of serrated cells, and cause inflammation and other series of problems.
[0007] Peptide nano-micelles are mostly used in the field of polypeptide drugs, and there have been many reports on their use in the treatment of cancer. CN112426537A discloses a polypeptide nano-micelle, a preparation method and an application thereof. The polypeptide nano-micelle is formed by self-assembly of polyethylene glycol phospholipids (PEG-PE) and polypeptides, and has the effect of inhibiting the proliferation of cancer cells. CN 112494427A discloses a polylactic acid-polypeptide micelle and its application, which is formed by self-assembly of amphiphilic polylactic acid-polypeptide polymers. The hydrophilic polypeptide forms the outer shell of the polylactic acid-polypeptide micelle, and the hydrophobic polylactic acid forms the inner core of the polylactic acid-polypeptide micelle; the amphiphilic polylactic acid-polypeptide polymer is also connected to an aptamer targeting tumor cells, which is of great significance in the field of combined treatment of tumors. The polypeptide nano-micelles provided by the above patents are used as drugs, but there are few reports on their application in beauty.
[0008] In summary, it is necessary to develop a method for preparing an anti-wrinkle polypeptide product with good skin permeability and high safety. Summary of the invention
[0009] The technical problem to be solved by the present invention is to overcome the difficulty of achieving both transdermal and efficacy of polypeptides while ensuring safety, provide a botulinum toxin-like polypeptide nano-micelle and a preparation method thereof, and apply them to the field of cosmetic technology.
[0010] The technical solution adopted to solve the above technical problems consists of the following steps:
[0011] A method for preparing botulinum-like polypeptide nano-micelles comprises the following steps:
[0012] (1) Design of botulinum-like peptides: Using Discovery studio software, based on the crystal structures of SNAP-25 and Rabphilin-3A, we simulated and designed a peptide sequence that could block the interaction between the two; and modified the nitrogen termini of the peptide sequences with hydrophobic groups;
[0013] (2) Preparation of botulinum-like peptides: synthesizing a crude peptide sequence modified with a hydrophobic group, purifying it, and freeze-drying it to obtain a purified botulinum-like peptide;
[0014] (3) Preparation of botulinum toxin-like peptide nano-micelles: The botulinum toxin-like peptide is prepared into a solution with a concentration greater than or equal to 0.2 mg / mL, at which point the botulinum toxin-like peptide self-assembles into nano-micelles. The peptide nano-micelle solution is characterized using a transmission electron microscope, and the sample is negatively stained with 3% phosphotungstic acid; the particle size of the sample is tested using dynamic light scattering, and the particle size is less than 50 nm. Botulinum toxin-like peptide micelles have significant anti-wrinkle effects and can also be used as a carrier to load other hydrophilic active ingredients.
[0015] In the above step (1), the hydrophobic group is modified to be myristoyl-modified or palmitoyl-modified.
[0016] In the above step (2), a resin is used as a carrier, a peptide solid phase organic synthesis technique is used, and a hydrophobic group-modified peptide sequence is synthesized in an N,N-dimethylformamide system using an Fmoc synthesis strategy, and then lyophilized after purification to obtain a purified peptide. Specifically:
[0017] Rink Aminde MBHA Resin was used as a carrier, and peptide solid phase organic synthesis technology was used to synthesize Myristoyl-Glu-Asn-Arg-Ser-Phe-Met-Glu-Leu-Glu-Glu-Met-Gln-Arg-Arg-Ala-NH2 in an N,N-dimethylformamide system using the Fmoc synthesis strategy. The protecting group was removed using a 20% piperidine / DMF solution, and the final nitrogen-terminal modification was performed using myristoyl chloride or palmitoyl chloride to obtain a fully protected peptide resin. The fully protected peptide resin is cleaved under the action of trifluoroacetic acid and the side chain protecting groups of the polypeptide are removed to obtain a crude polypeptide; the polypeptide is purified by reverse phase preparative liquid chromatography, filler: C18, 0.1% TFA / H2O in phase A, 0.1% TFA / MeOH in phase B, balanced loading in phase A, elution procedure: 25%-85% for 60 min, and lyophilized after preparation and purification to obtain a purified polypeptide; or a purified polypeptide having a synthetic sequence of Palmitoyl-ENRSFMELEEMQRRA-NH2 is obtained.
[0018] (4) Efficacy verification of the botulinum toxin-like polypeptide nanomicelles prepared by the present invention:
[0019] Permeability test: Fluorescently labeled botulinum-like peptide nano-micelles and fluorescently labeled pentapeptide (pentapeptide disclosed in CN113512092A) were used to detect the distribution of samples in pig skin and evaluate permeability. The permeability of peptides was significantly enhanced in the form of nano-micelles.
[0020] Anti-wrinkle effect: Based on fibroblasts, the changes in cell proliferation and cell migration after the action of botulinum toxin peptide nano-micelle samples were detected; UVA was used to irradiate fibroblasts, and the changes in the content of type I collagen (Collagen I) protein and matrix metalloproteinase 1 (MMP-1) were detected, indicating that botulinum toxin peptide nano-micelles have significant anti-wrinkle effects; based on ex vivo skin tissue, the changes in collagen density and type IV collagen (Collagen IV) content were detected, indicating that botulinum toxin peptide nano can achieve anti-wrinkle effects. Based on neuronal cells, the content of the neurotransmitter acetylcholine was tested at the 2D cell level and the 3D skin model level using a colorimetric method. Compared with the control group (hexapeptide), the acetylcholine content of the botulinum toxin peptide nano-micelles was significantly reduced, achieving a strong anti-wrinkle effect.
[0021] (5) Botulinum toxin-like peptide nanomicelles are nanoparticles formed by self-assembly of amphiphilic molecules. Their structure includes a lipophilic core and a hydrophilic shell. The hydrophilic shell can bind to the hydrophilic active ingredient through non-covalent bonds (such as van der Waals forces and intermolecular hydrogen bonds) to form supramolecular nanoparticles.
[0022] Through computer bionic simulation of human type I collagen, a hydrophilic peptide with 21 amino acids was designed. Its sequence is Ac-GP-(Hyp)-GP-(Hyp)-GF-(Hyp)-GERGP-(Hyp)-GP-(Hyp)-GP-(Hyp)-NH2. It has been biologically verified to have firming and anti-aging effects. Transmission electron microscopy showed that the structure of the nanomicelles after binding was nanoparticles, forming supramolecular nanoparticles with a particle size of about 100nm. The sequence of the collagen peptide is: Ac-Gly-Pro-Hyp-Gly-Pro-Hyp-Gly-Phe-Hyp-Gly-Glu-Arg-Gly-Pro-Hyp-Gly-Pro-Hyp-Gly-Pro-Hyp-NH2. Through the efficacy verification at the cell and tissue levels: Botulinum toxin-like peptide nanomicelles loaded with collagen peptides can not only play an anti-wrinkle effect, but also a firming and anti-aging effect.
[0023] (6) A hydrophilic bee venom peptide with a sequence of H-GIGAVLKVLTTGLPALISWIKRKRQQ-NH2 is selected, which has significant anti-inflammatory effects and can be combined with the hydrophilic shell of the botulinum toxin-like peptide nanomicelles and applied to cosmetics to exert a soothing effect while anti-wrinkle. The hydrophilic shell of the botulinum toxin-like peptide nanomicelles is loaded with hydrophilic bee venom peptide, which is self-assembled through non-covalent bonds to form supramolecular nanoparticles with a particle size of about 100 nm.
[0024] In the above step (2), the degree of substitution of Rink Amide MBHA Resin is preferably 0.5-0.6 mmol / g.
[0025] In the above step (3), the concentration of the botulinum toxin-like polypeptide nanomicelle solution is preferably 0.2 mg / mL. Transmission electron microscopy shows that if the concentration is less than 0.2 mg / mL, nanoparticles cannot be formed.
[0026] In the above step (4), the carboxyl terminus of the botulinum toxin-like peptide is preferably labeled with Cy5, and then prepared into nano-micelles after fluorescent labeling; hexapeptide is preferably used as a control group for efficacy verification of competitive products, and an anti-wrinkle activity comparison experiment is carried out with the botulinum toxin-like nano-micelles.
[0027] In the above step (5), the concentration ratio of the botulinum toxin-like polypeptide nano-micelles to the collagen peptides is preferably 2:1.
[0028] In the above step (6), the concentration ratio of botulinum toxin-like polypeptide nano-micelles to melittin is preferably 2:1.
[0029] Compared with the prior art, the present invention has the following beneficial effects:
[0030] 1. The botulinum toxin-like polypeptide of the present invention is an amphiphilic molecule, which can self-assemble into nano-micelles in aqueous solution with the lipophilic group facing inward and the hydrophilic group facing outward. The nano-micelles can quickly penetrate the skin barrier, dissociate into polypeptide monomers after permeation, exert anti-wrinkle effects, and can be applied in the field of cosmetic technology.
[0031] 2. The present invention has developed an application technology of polypeptide nano-micelles, defined as POLYPP TM Polypeptide hypertonic delivery technology. By selecting more functional polypeptides, they are self-assembled into supramolecular spherical microcapsules through biological modification to play a role between cells. The botulinum-like polypeptide nanomicelles of the present invention have a polypeptide sequence containing 15 amino acids. The length of 15 amino acids itself is difficult to penetrate the skin, but after the present invention forms it into nanomicelles, it can quickly penetrate the skin, perfectly solving the problem that long peptides in cosmetics have strong efficacy but difficult to penetrate the skin, and realizing the innovation of the delivery method of cosmetic polypeptides. The entire preparation process does not contain any exogenous substances, completely avoiding the addition of nanogold, with high biocompatibility and high safety. Compared with the commercially available product hexapeptide, the anti-wrinkle effect is doubled.
[0032] 3. General polypeptide nanomicelles include a lipophilic core and a hydrophilic shell. In the field of pharmaceutical peptides, polypeptide nanomicelles mostly use their lipophilic cores to embed or load some poorly water-soluble pharmacological molecules to increase the drug loading capacity, but there are few reports on the function of their hydrophilic shells. The botulinum toxin-like polypeptide nanomicelles disclosed in the present invention include a lipophilic core and a hydrophilic shell. The hydrophilic shell can load hydrophilic polypeptides with other functions. While exerting the anti-wrinkle effect of botulinum toxin, it also exerts other functions, such as combining with collagen peptides to exert a firming effect, and combining with bee venom peptides to exert anti-inflammatory and soothing effects, thereby achieving the technical effect of dual-peptide dual effects. BRIEF DESCRIPTION OF THE DRAWINGS
[0033] Figure 1 is the HPLC spectrum of botulinum-like peptides;
[0034] Figure 2 This is the ESI-MS spectrum of the botulinum-like peptide, M = 2135.3;
[0035] Figure 3 The transmission electron microscopy image (TEM image) of botulinum-like peptide nanomicelles (CMC = 0.2 mg / mL) has a particle size of less than 50 nm;
[0036] Figure 4 This is a transmission electron microscopy image of a botulinum-like peptide nanomicelle solution at a concentration of 0.1 mg / mL;
[0037] Figure 5 This is a penetration experiment based on the fluorescence intensity of botulinum toxin-like peptide nanomicelles on suckling pig skin;
[0038] A, fluorescence microscopy observation, B, cumulative penetration;
[0039] Figure 6 The results of the cell proliferation experiment of botulinum toxin-like peptide nano-micelles based on fibroblasts;
[0040] Figure 7 The results of the cell migration experiment of botulinum toxin-like peptide nanomicelles based on fibroblasts;
[0041] A, 4x microscope image, B, average relative mobility;
[0042] Figure 8 The experimental results of Collage I based on the anti-wrinkle validation of UVA-irradiated fibroblasts in vitro;
[0043] Fig. 9 The experimental results of detecting matrix metalloproteinase MMP-1 based on the anti-wrinkle validation of UVA-irradiated fibroblasts in vitro;
[0044] Fig.10 To verify the anti-wrinkle effect of UVA-irradiated ex vivo skin - to test the collagen density results;
[0045] Fig.11 To verify the anti-wrinkle effect of UVA-irradiated ex vivo skin - to detect the content of Collagen IV;
[0046] A, staining image, B, relative IOD / Area average value;
[0047] Fig.12 This is the result of the test of the neurotransmitter acetylcholine content based on HT22 cells;
[0048] Fig.13 To compare the safety of introduction of botulinum-like peptide nanomicelles and gold nanopeptide hybrids;
[0049] A, post-operative photo of the polypeptide nanohybrid, B, post-operative photo of the botulinum toxin-like polypeptide micelle of the present invention;
[0050] Fig.14 ESI-MS of collagen peptide: M = 2055,3;
[0051] Fig.15 This is the TEM image of botulinum-like collagen composite nanomicelles, with a particle size of less than 100 nm;
[0052] Fig.16 The collagen fiber content was detected in the ex vivo skin based on UV stimulation by using botulinum toxin-like peptide nano-micelles loaded with collagen peptides.
[0053] A, staining image, B, relative IOD / Area average value;
[0054] Fig.17 is the ESI-MS spectrum of melittin, M=2846.5;
[0055] Fig.18 This is the TEM image of botulinum-like bee venom composite nanomicelles, with a particle size of about 100 nm;
[0056] Fig.19 The results of anti-inflammatory experiments on macrophages based on botulinum-like bee venom nanomicelles.
[0057] It should be noted that in the accompanying drawings of the present invention, in order to simplify the labeling, the botulinum toxin-like polypeptide nanomicelles are labeled as Taishu; the nanomicelles formed by botulinum toxin-like polypeptide loaded with collagen peptide are drawn using "Taishu collagen peptide", and the nanomicelles of botulinum toxin-like polypeptide loaded with bee venom peptide are drawn using "Taishu bee venom peptide". DETAILED DESCRIPTION
[0058] In order to enable those skilled in the art to better understand and implement the technical solution of the present invention, the present invention is further described below in conjunction with specific embodiments and drawings.
[0059] In the description of the present invention, unless otherwise specified, all reagents used are commercially available and all methods used are conventional techniques in the art.
[0060] The abbreviations in the specification are explained below: Rink Amide MBHA Resin (Tianjin Nankai Hecheng Technology Co., Ltd.), degree of substitution is 0.5 mmol / g; OtBu: tert-butoxy; Trt: trityl; Pbf: 2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl; tBu: tert-butyl; Myristoyl-Cl: myristoyl chloride; Palmitoyl-Cl: palmitoyl chloride.
[0061] The analytical HPLC was Agilent 1260; the preparative HPLC was Chuangxin Hengtong LC3000, the C18 analytical column was 4.6 mm × 250 mm from Dalian Institute of Physical Chemistry, and the C18 preparative column was 10 cm × 65 cm from Chengdu Science Biology Co., Ltd.; the mass spectrometer was Waters UPLC-LC-MS.
[0062] Example 1
[0063] A botulinum toxin-like polypeptide nanomicelle, the botulinum toxin-like polypeptide sequence is: R-Glu-Asn-Arg-Ser-Phe-Met-Glu-Leu-Glu-Glu-Met-Gln-Arg-Arg-Ala-NH2 (SEQ ID NO.1), R is Myr (myristoyl) or Pal (palmitoyl).
[0064] Example 2
[0065] A method for preparing botulinum-like polypeptide nano-micelles, comprising:
[0066] 1. Design and preparation of botulinum toxin-like peptides
[0067] (1) Computer simulation design of peptide sequences:
[0068] Based on the crystal structures of SNAP-25 and Rabphilin-3A, natural amino acid mutations were performed on the corresponding amino acid sites using Discovery studio software, and then energy minimization simulations were performed on the mutant complex protein according to the energy minimization principle. Based on computational chemistry, the hydrophilicity and charge distribution of the peptide were calculated to obtain the optimal sequence: ENRSFMELEEMQRRA. The nitrogen end of the peptide was modified with hydrophobic groups, preferably myristoyl modification, to obtain Myr-ENRSFMELEEMQRRA-NH2;
[0069] (2) Synthesis of botulinum-like peptides:
[0070] (2.1) Synthesis of Fmoc-Ala-Rink Amide MBHA Resin
[0071] Weigh 10g Rink Amide MBHA Resin (SD = 0.5mmol / g), add it to the synthesis column, swell it with 80mL N,N-dimethylformamide for 4 hours, filter it to remove the solvent, remove the Fmoc protecting group with 80mL of N,N-dimethylformamide solution with a volume concentration of 20% piperidine for 40 minutes, filter it, and wash the filter cake with isopropanol and N,N-dimethylformamide twice, 80mL each time. The resin is black when tested with ninhydrin. Add 100mL to the synthesis column. N,N-dimethylformamide, 3.1g (10mmol) Fmoc-Ala-OH, 2g (15mmol) 1-hydroxybenzotriazole, 2.3mL (15mmol) N,N′-diisopropylcarbodiimide, under nitrogen protection, stir and react at room temperature for 2 hours. The resin is colorless and transparent when detected by ninhydrin. The resin is washed with isopropanol and N,N-dimethylformamide in turn to obtain Fmoc-Ala-Rink Amide MBHA Resin.
[0072] (2.2) Synthesis of Fmoc-protected fully protected peptide resin
[0073] According to the synthesis strategy of step (2.1), 6.4 g (10 mmol) Fmoc-Arg (Pbf) -OH, 6.4 g (10 mmol) Fmoc-Arg (Pbf) -OH, 6.1 g (10 mmol) Fmoc-Gln (Trt) -OH, 3.7 g (10 mmol) Fmoc-Met-OH, 4.2 g (10 mmol) Fmoc-Glu (OtBu) -OH, 4.2 g (10 mmol) Fmoc-Glu (OtBu) -OH, 3.5 g Fmoc-Leu-OH, 4.2 g (10 mmol) Fmoc-Glu (OtBu) -OH, 3.7 g (10 mmol) Fmoc-Met- ...3.7 g (10 mmol) Fmoc-Met-OH, 3.7 g (10 mmol) Fmoc-Met-OH, ol)Fmoc-Met-OH, 3.8gFmoc-Phe-OH, 3.8gFmoc-Ser(tBu)-OH, 6.4g(10mmol)Fmoc-Arg(Pbf)-OH, 5.9gFmoc-Asn(Trt)-OH, 4.2g(10mmol)Fmoc-Glu(OtBu)- OH, synthesized to obtain Fmoc-Glu(OtBu)-Asn(Trt)-Arg(Pbf)-Ser(tBu)-Phe-Met-Glu(OtBu)-Leu-Glu(OtBu)-Glu(OtBu)-Met-Gln(Trt)-Arg(Pbf)-Arg(Pbf)-Ala-Rink Amide MBHA Resin.
[0074] (2.3) Use 20% piperidine / DMF solution to remove the protecting group, and use myristoyl chloride to perform the final nitrogen end modification to obtain a fully protected peptide resin. The details are as follows:
[0075] 80 mL of 20% piperidine in N, N-dimethylformamide solution was added to the synthesis column to remove the Fmoc protecting group for 40 minutes, and the filter cake was washed twice with isopropanol and N, N-dimethylformamide, 80 mL each time. The ninhydrin detection resin was black. 100 mL of dichloromethane, 7 mL of myristoyl chloride, and 15 mL of N, N-diisopropylethylamine were added to the synthesis column and reacted for 1 hour. The ninhydrin detection resin was colorless and transparent to obtain Myr-Glu(OtBu)-Asn(Trt)-Arg(Pbf)-Ser(tBu)-Phe-Met-Glu(OtBu)-Leu-Glu(OtBu)-Glu(OtBu)-Met-Gln(Trt)-Arg(Pbf)-Arg(Pbf)-Ala-RinkAmide MBHA Resin was washed and dried with isopropanol, N,N-dimethylformamide and methanol in turn.
[0076] (2.4) The fully protected peptide resin is cleaved under the action of trifluoroacetic acid and the side chain protecting groups of the polypeptide are removed to obtain a crude polypeptide. Specifically, 132 mL of trifluoroacetic acid, 7.5 mL of triisopropylsilane, 6 mL of thioanisole, and 4.5 mL of water are added to the dried resin, reacted for 2.5 hours, filtered, the filtrate is concentrated, TFA is removed under reduced pressure, 10 times the volume of cold ether is added to the concentrate, crystallized and stirred for 1 hour, filtered, the filter cake is collected, and vacuum dried to obtain a crude botulinum-like polypeptide (trifluoroacetate salt);
[0077] (2.5) Purification:
[0078] Add 50% acetonitrile aqueous solution to the crude botulinum-like polypeptide, add a small amount of trifluoroacetic acid to assist dissolution, filter, adjust volume, and prepare and purify on reverse phase chromatography (filler: C18), chromatographic procedure: 0.1% TFA / H2O (v / v) in phase A, 0.1% TFA / ACN (v / v) in phase B, balance loading in phase A, elution procedure: 25%-85% for 60 min, collect eluate. Use 50mmol / L ammonium acetate buffer for salt conversion, elution procedure: 55%-85% for 60 min, freeze-dry, and obtain 5.1g of pure botulinum-like polypeptide acetate (hereinafter referred to as botulinum-like polypeptide freeze-dried powder), namely Myr-Glu-Asn-Arg-Ser-Phe-Met-Glu-Leu-Glu-Glu-Met-Gln-Arg-Arg-Ala-NH2, with a yield of 48%.
[0079] The structure and purity of the peptide were characterized by high performance liquid chromatography and mass spectrometry. Figure 1 As shown). Electrospray mass spectrometry ESI-MS was used for structural characterization: (M+3H / 3,100) (as shown Figure 2 shown).
[0080] Supplementary explanation: When R in the amino acid sequence of the botulinum-like peptide is palmitoyl-modified, the preparation method can refer to the preparation method of the myristoyl-modified peptide, but the myristoyl-modified part needs to be replaced. Other chemical methods can also be used to synthesize the amino acid sequence of the botulinum-like peptide.
[0081] 2. Preparation of polypeptide nanomicelles
[0082] 10 mg, 25 mg, and 50 mg of myristoyl-modified botulinum-like peptide lyophilized powder were weighed respectively, and added into 50 mL of double distilled water to prepare 0.2 mg / mL, 0.5 mg / mL, and 1 mg / mL solutions, and ultrasonically oscillated for 5 min-10 min to obtain a colorless solution of botulinum-like peptide nanomicelles.
[0083] 3. Structural characterization of peptide nanomicelles
[0084] The peptide nanomicelle solution was characterized using a transmission electron microscope. The sample was negatively stained with 3% phosphotungstic acid. The particle morphology at different concentrations was detected. The sample at 1 mg / mL, 0.5 mg / mL, and 0.2 mg / mL concentrations all showed nanoparticle morphology (e.g. Figure 3 The particle size was detected by dynamic light scattering, and the particle size was less than 50 nm.
[0085] Through experimental measurement, it is found that at a concentration of 0.2 mg / mL, the peptide solution can form nano-micelles, but at a concentration of less than 0.2 mg / mL, nano-micelles cannot be formed. Figure 4 As shown, at a concentration of 0.1 mg / mL, nanoparticles were barely observable.
[0086] 4. Permeability test of peptide nanomicelles
[0087] Based on the suckling pig skin-Franz cell system, the distribution of fluorescently labeled botulinum-like peptide nano-micelles and fluorescently labeled pentapeptide (the pentapeptide disclosed in CN113512092A was used in the permeability test experiment of peptide nano-micelles) in pig skin at different time points was observed by fluorescence microscopy to evaluate the skin permeation behavior of different samples. The method is as follows:
[0088] (1) Fluorescent labeling of peptides: The botulinum toxin-like peptide was dissolved in an aqueous solution, and 1.2 equivalents of Cy5 fluorescent dye were added. The mixture was reacted in the dark for 24 h, and then lyophilized after dialyzation to obtain a red lyophilized powder. Fluorescently labeled botulinum toxin-like peptide nanomicelles were prepared in turn. As a control group, the 15-peptide was also fluorescently labeled with Cy5.
[0089] (2) Based on the suckling pig skin-Franz cell system, the distribution of fluorescent labeled substances in pig skin at different time points was observed by fluorescence microscopy to evaluate the skin penetration behavior of different samples.
[0090] (3) Experimental results: The fluorescence intensity values at 2h and 4h indicated that the cumulative permeation of botulinum toxin-like peptide nanomicelle fluorescent marker and 15-peptide fluorescent marker was greater than that at the previous time point, that is, the sample permeation increased with time; the order of cumulative permeation at 2h and 4h was: botulinum toxin-like peptide nanomicelle fluorescent marker > 15-peptide fluorescent marker (e.g. Figure 5 The final results show that the transdermal permeability of the botulinum toxin-like polypeptide nano-micelles of the present invention is much higher than that of the pentapeptide.
[0091] 5. Verification of the anti-wrinkle activity of peptide nanomicelles
[0092] (1) Fibroblast-based cell proliferation test:
[0093] Based on fibroblasts, the changes in cell proliferation and cell migration after the action of the samples were detected; UVA was used to irradiate fibroblasts, and the changes in the content of type I collagen (Collagen I) protein and matrix metalloproteinase 1 (MMP-1) after the action of the samples were detected to evaluate the anti-wrinkle effect of the samples to be tested.
[0094] Prepare sample working solution according to Table 1 and incubate in an incubator overnight.
[0095] Table 1 Preparation of samples for fibroblast-based cell proliferation test
[0096]
[0097]
[0098] Note: “ / ” indicates no related operation.
[0099] The drugs were administered according to the test scheme in Table 1, and the cells were cultured in the incubator for 24h, 48h, and 72h, respectively. After the cells were incubated, the supernatant was discarded, and MTT working solution (0.5mg / mL, prepared immediately) was added. The cell viability was calculated according to the formula, and graphed using GraphPadPrism. The results were expressed as Mean±SD. The t-test statistical analysis was used for comparison between the groups. All statistical analyses were two-tailed. P<0.05 was considered to be significantly different, and P<0.01 was considered to be extremely significantly different. The results showed that compared with the blank control group (hexapeptide), the cell viability of the botulinum toxin-like peptide nanomicelles was significantly increased after 24h, 48h, and 72h of administration, with the increase rates being 12.92%, 42.77%, and 60.98%, respectively. Figure 6 shown.
[0100] (2) Fibroblast-based cell scratch test (fibroblast-based cell migration experiment): Cell inoculation, solution preparation, drug administration, and sample incubation are completed before scratching. Use a 5mL pipette tip to make two vertical scratches in the six-well plate, with the vertical scratch as the baseline (the pipette tip is perpendicular to the edge of the ruler), and the scratch spacing is kept at 2 cm; after making the vertical scratch, make a horizontal scratch perpendicular to the baseline near the center axis of the six-well plate. When scratching with the pipette tip, try to use uniform force and keep the width of the scratch consistent. After the scratch, wash the cells three times with PBS, add normal cell culture medium, and culture in an incubator (37°C, 5% CO2) for 24 hours. Take pictures under a 4x microscope at 0 hours after scratching, and wash once with PBS after 24 hours, and take pictures under a 4x microscope. The migration rate of the blank control (BC) group is normalized, and the relative migration rate of each group is calculated. The results show that compared with the blank control group, the cell migration rate of botulinum-like peptide nano-micelles and hexapeptide was significantly increased 24 hours after administration, with the increase rates being 56% and 37%, respectively. Compared with the hexapeptide group, the cell migration rate of the botulinum toxin-like peptide nanomicelles increased, e.g. Figure 7 shown.
[0101] (3) Anti-wrinkle efficacy test based on UVA-stimulated fibroblasts: Cell inoculation, liquid preparation according to the following table.
[0102] Table 2 Anti-wrinkle efficacy test sample preparation based on UVA stimulation of fibroblasts
[0103]
[0104]
[0105] Note: “ / ” indicates no related operation.
[0106] According to the test scheme in Table 2 above, the grouping and administration were carried out, and the cells were incubated in an incubator (37°C, 5% CO2) for 24 hours. According to the test scheme, the groups that needed irradiation were irradiated with UVA, and the irradiation dose was 30 J / cm 2 . After the irradiation, the cells were placed in an incubator (37°C, 5% CO2) and cultured for another 24 hours. Sample collection: After 24 hours of culture, the cell culture supernatant was collected in an EP tube and stored in a -80°C refrigerator. After 24 hours of culture, the cell culture supernatant was collected in an EP tube and stored in a -80°C refrigerator. The test was performed according to the operating instructions of the ELISA kit, and GraphPad Prism was used for graphing. The results were expressed as Mean±SD. The results showed that compared with the negative control group, the Collagen I content of botulinum toxin-like peptide nanomicelles and hexapeptide increased significantly, with an increase rate of 107.73% and 21.73% respectively.
[0107] Compared with the hexapeptide group, the collagen I content in the Taishu group increased significantly (e.g. Figure 8 Compared with the negative control group, the content of matrix metalloproteinase MMP-1 in peptide nano-micelles and hexapeptide was significantly decreased, with a decrease rate of 28.05% and 19.44% respectively. Compared with the hexapeptide group, the content of MMP-1 in the botulinum toxin-like peptide nano-micelle group was significantly decreased (as shown in Figure 2A). Fig. 9 shown).
[0108] (4) Anti-wrinkle efficacy test based on ex vivo skin tissue: Prepare sample working solution according to the following table.
[0109] Table 3 Anti-wrinkle efficacy test sample preparation based on ex vivo skin tissue
[0110]
[0111]
[0112] Note: “ / ” indicates no related operation.
[0113] The freshly obtained skin tissue was immersed in 75% alcohol and washed for 30 seconds, and then washed three times with sterile PBS buffer; after that, the skin was cut into 24±2mm 2 The tissue blocks were placed in a culture mold, and then the culture mold was transferred to a 6-well plate, 3.7 mL of culture medium was added to each well, and cultured in a 37°C, 5% CO2 incubator, with the medium changed every day; after 2 days of in vitro skin tissue culture, irradiation and drug administration were started with reference to the test scheme and corresponding treatment conditions in Table 3; the irradiation dose was UVA (30 J / cm 2 ) and UVB (50mJ / cm 2 ), irradiated continuously for 4 days, replaced with fresh culture medium after each irradiation, and administered, the sample to be tested was administered by surface administration; after 4 days of continuous irradiation, the ex vivo skin tissue was cultured for another 3 days, during which time no irradiation was performed, and only sample administration was performed. The test was performed according to the specific operating steps of immunohistochemistry, and the skin ultrasound instrument was used to detect the collagen density according to the specific operating steps. GraphPad Prism was used to draw the graph, and the results were expressed as Mean±SD. The results showed that compared with botulinum injections, the collagen density content of the botulinum-like peptide nano-micelle group increased (such as Fig.10 Compared with botulinum injection, the content of Collagen IV in the botulinum toxin-like peptide nano-micelle group increased (as shown in Fig.11 shown).
[0114] (5) Detection of acetylcholine content based on HT22 cells: Based on mouse hippocampal neurons, the content of neurotransmitter acetylcholine was tested using a colorimetric method at the 2D cell level and 3D skin model level, and hexapeptide was selected as a competitive control. The results showed that compared with the blank control group, the acetylcholine content in the hexapeptide and botulinum toxin-like peptide nanomicelle groups decreased significantly, with decrease rates of 23.29% and 49.60%, respectively. Compared with hexapeptide, the acetylcholine content in the botulinum toxin-like peptide nanomicelle group decreased significantly (e.g. Fig.12 shown).
[0115] (6) Verification of the safety of botulinum toxin-like peptide nanomicelles in humans
[0116] When the peptide nanohybrid containing nanogold is used in imported products, a series of adverse reactions will occur: when the botulinum toxin-like peptide micelle is used as an imported product, there will be no allergic irritation reaction. Fig.13 shown.
[0117] The polypeptide nanohybrid containing nanogold (the polypeptide nanohybrid structure disclosed in Example 1 of CN 113512092 A) was used for periorbital and forehead treatment with a total dosage of 0.4 ml. Slight swelling occurred immediately after the operation, accompanied by skin papules ( Fig.13 A). After seven days of use, the botulinum toxin peptide micelles can be seen to have lighter true wrinkles and a large number of fine lines have disappeared. VISIA data shows that eye wrinkles have improved by 76% and there is no skin irritation reaction ( Fig.13 B).
[0118] Example 3
[0119] A method for preparing botulinum-like peptide nano-micelles loaded with collagen peptides, comprising:
[0120] (1) Preparation of collagen peptides: Rink Amide MBHA Resin was selected and solid phase peptide synthesis technology was used to synthesize collagen peptides in a manner similar to that of botulinum toxin peptides to obtain crude collagen peptides; the crude collagen peptides were purified by reverse phase liquid preparative chromatography and freeze-dried to obtain pure collagen peptides, namely Ac-GP-(Hyp)-GP-(Hyp)-GF-(Hyp)-GERGP-(Hyp)-GP-(Hyp)-GP-(Hyp)-NH2. The molecular weight was determined by electrospray ionization mass spectrometry (ESI-MS). The ESI-MS of the collagen peptides was as follows: Fig.14 shown.
[0121] (2) Preparation of botulinum-like peptide nano-micelles loaded with collagen peptide: Weigh 3 mg of collagen peptide, dissolve it in 10 mL of pure water, and completely dissolve it by ultrasonication. Weigh 6 mg of botulinum-like peptide, dissolve it in 20 mL of pure water, mix the solution containing collagen peptide and the solution containing botulinum-like peptide, and stir to mix well, thus completing the preparation of botulinum-like collagen nano-composite materials (composite nano-micelles). The structural morphology was tested using a transmission electron microscope. The sample was negatively stained with 3% phosphotungstic acid, and its structural morphology was nanoparticles (such as Fig.15 shown).
[0122] (3) Firming and anti-wrinkle efficacy test based on ex vivo skin tissue: Prepare sample working solution according to the following table
[0123] Table 4 Preparation of samples for testing firming and anti-wrinkle efficacy based on ex vivo skin tissue
[0124]
[0125] Note: “ / ” indicates no related operation.
[0126] According to the method in Table 4, the tissue was treated and then administered. After 2 days of in vitro skin tissue culture, it was irradiated and administered according to the conditions. The irradiation was continued for 4 days. Fresh culture medium was replaced after each irradiation, and the drug treatment was performed. The sample to be tested was administered by surface administration. After the drug administration, the skin tissue was fixed with 4% paraformaldehyde, embedded in the tissue, and sliced for Masson staining. The slice results were recovered, photographed under a microscope, and used Plus image processing software was used for analysis. The results showed that compared with the commercially available palmitoyl pentapeptide-4, the collagen fiber content of the Taishu collagen peptide group increased (e.g. Fig.16 shown).
[0127] Example 4
[0128] A method for preparing botulinum-like peptide nano-micelles loaded with melittin, comprising:
[0129] (1) Preparation of melittin: Rink Amide MBHA Resin was selected and solid phase peptide synthesis technology was used to synthesize melittin in the manner of synthesizing botulinum toxin-like peptides to obtain crude melittin; the crude melittin was purified by reverse phase liquid preparative chromatography and freeze-dried to obtain pure melittin, i.e., H-GIGAVLKVLTTGLPALISWIKRKRQQ-NH2. The molecular weight was determined by electrospray ionization mass spectrometry (ESI-MS). The ESI-MS of melittin was as follows: Fig.17 shown.
[0130] (2) Preparation of botulinum-like bee venom composite nano-micelles: Weigh 3 mg of bee venom peptide, dissolve it in 10 mL of pure water, and completely dissolve it by ultrasonication. Weigh 6 mg of botulinum-like peptide, dissolve it in 20 mL of pure water, mix the solution containing bee venom peptide and the solution containing botulinum-like peptide, and stir to mix well, thus completing the preparation of botulinum-like bee venom nano-composite materials. The structural morphology was tested using a transmission electron microscope. The sample was negatively stained with 3% phosphotungstic acid, and its structural morphology was nanoparticles (such as Fig.18 shown).
[0131] (3) Macrophage-based anti-inflammatory assay: Samples were tested under the following conditions.
[0132] Table 5 Preparation of samples for testing firming and anti-wrinkle efficacy based on ex vivo skin tissue
[0133]
[0134] Note: “ / ” indicates no related operation.
[0135] The results showed that the sample Taishu Melittin could significantly reduce the IL-6 content, and the inhibition rate could reach 67.84%. Fig.19 shown.
[0136] It should be noted that when the present invention involves a numerical range, it should be understood that the two endpoints of each numerical range and any value between the two endpoints can be selected. Since the steps and methods used are the same as those in the embodiments, in order to avoid redundancy, the present invention describes a preferred embodiment. Although the preferred embodiments of the present invention have been described, those skilled in the art may make additional changes and modifications to these embodiments once they know the basic creative concept. Therefore, the attached claims are intended to be interpreted as including the preferred embodiments and all changes and modifications that fall within the scope of the present invention.
[0137] Obviously, those skilled in the art can make various changes and modifications to the present invention without departing from the spirit and scope of the present invention. Thus, if these modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include these modifications and variations.
Claims
1. A method for preparing botulinum toxin-like polypeptide nanomicelles, characterized in that: The following steps are involved: Design of botulinum-like peptides: Based on the crystal structures of SNAP-25 and Rabphilin-3A, a peptide sequence capable of blocking the interaction between the two was obtained by simulation design, and the nitrogen end of the peptide sequence was modified with a hydrophobic group; the hydrophobic group modification was myristoyl modification or palmitoyl modification; The amino acid sequence of the botulinum toxin-like peptide is: R-Glu-Asn-Arg-Ser-Phe-Met-Glu-Leu-Glu-Glu-Met-Gln-Arg-Arg-Ala-NH2, R is myristoyl or palmitoyl; Preparation of botulinum-like peptides: using resin as a carrier, using peptide solid phase organic synthesis technology, in N, N-dimethylformamide system, using Fmoc synthesis strategy, synthesizing hydrophobic group-modified botulinum-like peptides, purifying and freeze-drying to obtain purified botulinum-like peptides; Preparation of botulinum toxin-like peptide nano-micelles: The purified botulinum toxin-like peptide is prepared into a solution with a concentration of 0.2 mg / mL to 1 mg / mL, at which point the botulinum toxin-like peptide self-assembles into nano-micelles.
2. The botulinum toxin-like polypeptide nanomicelles prepared by the method according to claim 1, characterized in that: The critical micelle concentration of the botulinum toxin-like polypeptide nanomicelles is 0.2 mg / mL.
3. The use of the botulinum toxin-like polypeptide nano-micelles according to claim 2, characterized in that: The botulinum toxin-like polypeptide nano micelles are used for preparing anti-wrinkle and anti-aging products.
4. The use of the botulinum toxin-like polypeptide nano-micelles according to claim 3, characterized in that: The nano micelle structure comprises a lipophilic core and a hydrophilic shell, wherein the hydrophilic shell can load a hydrophilic active ingredient through a non-covalent bond, and has the efficacy of the active ingredient while resisting wrinkles.
5. The use of the botulinum toxin-like polypeptide nano-micelles according to claim 2, characterized in that: The botulinum toxin-like polypeptide nano-micelle hydrophilic shell is loaded with hydrophilic collagen peptide or bee venom peptide to form supramolecular nanoparticles, which are used for preparing beauty products.
6. The use of the botulinum toxin-like polypeptide nano-micelles according to claim 2, characterized in that: When the botulinum toxin-like polypeptide nano-micelles are loaded with collagen peptides, they are in the form of botulinum toxin-collagen composite nano-micelles for preparing anti-wrinkle and firming products.
7. The use of the botulinum toxin-like polypeptide nano-micelles according to claim 2, characterized in that: When the botulinum-like polypeptide and bee venom peptide form supramolecular nanoparticles, the structure thereof is a botulinum-like bee venom composite nanomicelle, which is used for preparing anti-wrinkle and soothing products.
